help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0488
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, Y.
Right arrow Articles by Rosen, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, Y.
Right arrow Articles by Rosen, E. M.
Molecular Endocrinology 20 (1): 14-34
Copyright © 2006 by The Endocrine Society

The Breast Cancer Susceptibility Gene BRCA1 Regulates Progesterone Receptor Signaling in Mammary Epithelial Cells

Yongxian Ma1, Pragati Katiyar1, Laundette P. Jones, Saijun Fan, Yiyu Zhang, Priscilla A. Furth and Eliot M. Rosen

Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, D.C. 20057-1469

Address all correspondence and requests for reprints to: Eliot M. Rosen, Department of Oncology, Lombardi Cancer Center, Georgetown University, 3970 Reservoir Road, NW, Preclinical Sciences Building, Room GM12B, Washington, DC 20057-1469. E-mail: emr36{at}georgetown.edu.

The progesterone receptor (PR) plays roles in normal mammary development and breast cancer formation, where it may exert both stimulatory and inhibitory actions. Previously, the breast cancer susceptibility gene product BRCA1 was found to interact with and inhibit the transcriptional activity of estrogen receptor-{alpha}. In this study, we found that exogenous wild-type BRCA1 inhibited the activity of the PR in transient transfection assays utilizing a mouse mammary tumor virus-Luc reporter. Wild-type BRCA1 inhibited the activity of endogenous PR in human breast cancer cells (T47D and MCF-7) and inhibited the activity of exogenous PR-A, PR-B, and [PR-A plus PR-B] isoforms. On the other hand, knockdown of endogenous BRCA1 using small interfering RNA enhanced the progesterone-stimulated activity of the PR by about 4-fold. We documented an in vivo association of the endogenous BRCA1 with PR isoforms A and B and a direct in vitro interaction between BRCA1 and PR, which was partially mapped. Whereas down-regulation of the coactivator p300 contributes to the BRCA1-mediated repression of estrogen receptor-{alpha}, this mechanism does not contribute to inhibition of PR activity, because exogenous p300 did not rescue the BRCA1 repression of PR activity. The BRCA1-PR interaction has functional consequences. Thus, we showed that BRCA1 inhibits the expression of various endogenous progesterone-responsive genes and inhibits progesterone-stimulated proliferation of T47D cells. Finally, exogenous progesterone caused an exaggerated proliferative response in the mammary glands of mice harboring a mammary-targeted conditional deletion of the full-length isoform of Brca1. These findings suggest that BRCA1 regulates the activity of progesterone, a major hormone of pregnancy that may also participate in mammary carcinogenesis.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα  |  PR
Coregulators:   BRCA1  |  p300
Ligands:   17β-Estradiol  |  Progesterone



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
P. Katiyar, Y. Ma, A. Riegel, S. Fan, and E. M. Rosen
Mechanism of BRCA1-Mediated Inhibition of Progesterone Receptor Transcriptional Activity
Mol. Endocrinol., August 1, 2009; 23(8): 1135 - 1146.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. L. Kleinberg, T. L. Wood, P. A. Furth, and A. V. Lee
Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions
Endocr. Rev., February 1, 2009; 30(1): 51 - 74.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Magklara and C. L. Smith
A Composite Intronic Element Directs Dynamic Binding of the Progesterone Receptor and GATA-2
Mol. Endocrinol., January 1, 2009; 23(1): 61 - 73.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. A. Tone, H. Begley, M. Sharma, J. Murphy, B. Rosen, T. J. Brown, and P. A. Shaw
Gene Expression Profiles of Luteal Phase Fallopian Tube Epithelium from BRCA Mutation Carriers Resemble High-Grade Serous Carcinoma
Clin. Cancer Res., July 1, 2008; 14(13): 4067 - 4078.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. M. Silva and M. A. Shupnik
Integration of Steroid and Growth Factor Pathways in Breast Cancer: Focus on Signal Transducers and Activators of Transcription and Their Potential Role in Resistance
Mol. Endocrinol., July 1, 2007; 21(7): 1499 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. M. Eakin, M. J. MacCoss, G. L. Finney, and R. E. Klevit
Estrogen receptor {alpha} is a putative substrate for the BRCA1 ubiquitin ligase
PNAS, April 3, 2007; 104(14): 5794 - 5799.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. J. Poole, Y. Li, Y. Kim, S.-C. J. Lin, W.-H. Lee, and E. Y.-H. P. Lee
Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist
Science, December 1, 2006; 314(5804): 1467 - 1470.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society